Long term effect of infection control practices and associated factors during a major Clostridium difficile outbreak in Costa Rica

Journal of Infection in Developing Countries

Volumn 7, Issue 12, 2013, Pages 914-921

  Wong McClure, Roy A ^a   Ramírez Salas, Elenita ^a   Mora Brenes, Nury ^b   Aguero Sandí, Lorena ^a   Morera Sigler, Maritza ^a   Badilla Vargas, Xiomara ^a   Hernández de Merzerville, Marcela ^c   O'Shea, Michele ^d   Bryce, Elizabeth ^e  

^a Office of Epidemiology Surveillance   (Costa Rica)

^b HOSPITAL SAN JUAN DE DIOS   (Costa Rica)

^c HOSPITAL NACIONAL DE NIÑOS   (Costa Rica)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Clostridium difficile; Enterocolitis; Infection control; Infectious disease outbreaks

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; CEFALEXIN; CEFALOTIN; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; GENTAMICIN; LANSOPRAZOLE; LEVOFLOXACIN; LINEZOLID; MEROPENEM; NEOMYCIN; OMEPRAZOLE; OXACILLIN; PENICILLIN DERIVATIVE; SULFAMETHOXAZOLE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; COSTA RICA; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIARRHEA; DYSPNEA; FECES ANALYSIS; FEMALE; HEADACHE; HUMAN; IMMUNOASSAY; INFANT; INFECTION CONTROL; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; VOMITING; WEAKNESS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COSTA RICA; CROSS INFECTION; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DISEASE OUTBREAKS; FEMALE; HOSPITALS; HUMANS; INCIDENCE; INFECTION CONTROL; MALE; MIDDLE AGED; TIME;

EID: 84890467931     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2854     Document Type: Article

References (22)

1. Al-Tawfiq JA, Abed MS (2010) Clostridium difficileassociated disease among patients in Dhahran, Saudi Arabia. Travel Med Infect Dis 8: 373-376.
2. Sundram F, Guyot A, Carboo I, Green S, Lilaonitkul M, Scourfield A (2009) Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors. J. Hosp. Infect 72: 111-118.
3. O'Connor JR, Johnson S, Gerding DN (2009) Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136: 1913-1924.
4. Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert Bennett E (2010) Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 38 Suppl 1: 25-33.
5. Ananthakrishnan AN (2011) Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol 8: 17-26.
6. Indra A, Huhulescu S, Fiedler A, Kernbichler S, Blaschitz M, Allerberger F (2009) Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008-2009. Euro Surveill 14: 1-2
7. Labbé AC, Poirier L, Maccannell D, Louie T, Savoie M, Béliveau C, Laverdière M, Pépin J (2008) Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother 52: 3180-3187.
8. Perera AD, Akbari RP, Cowher MS, Read TE, McCormick JT, Medich DS, Celebrezze JP, Beck SJ, Fischer PE, Caushaj PF (2010) Colectomy for fulminant Clostridium difficile colitis: predictors of mortality. Am Surg 76: 418-421.
9. Viswanathan VK, Mallozzi MJ, Vedantam G (2010) Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions. Gut Microbes 1: 234-242.
10. Balassiano IT, Dos Santos Filho J, de Oliveira MP, Ramos MC, Japiassu AM, Dos Reis AM, Brazier JS, de Oliveira Ferreira E, Domingues RM (2010) An outbreak case of Clostridium difficile-associated diarrhea among elderly inpatients of an intensive care unit of a tertiary hospital in Rio de Janeiro, Brazil. Diagn Microbiol Infect Dis 68: 449-455.
11. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Harding RM, O'Connor L, Griffiths D, Vaughan A, Finney J, Wilcox MH, Crook DW, Peto TE (2012) Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med 9:e1001172.
12. Villalobos-Zúñiga MA, Boza-Cordero R (2012) Caracterización epidemiológica, clínica y microbiológica del brote de diarrea asociado a Clostridium difficile, ocurrido en el Hospital San Juan de Dios, 2008-2009. Acta Médica Costarricense 54: 152-158.
13. Camacho-Ortiz A, Galindo-Fraga A, Rancel-Cordero A, Macías AE, Lamothe-Molina P, Ponce de Leon-Garduno A, Sifuentes-Osornio J (2009) Factors associated with Clostridium difficile disease in a tertiary-care medical institution in Mexico: a case-control study. Rev Invest Clin 61: 371-377.
14. Quesada-Gómez C, Rodríguez C, Gamboa Coronado Mdel M, Rodríguez-Cavallini E, Du T, Mulvey MR, Villalobos Zúñiga M, Boza-Cordero R (2010) Emergence of Clostridium difficile NAP1 in Latin America. J Clin Microbiol 48: 669-670.
15. Edwardes M (2001) Sample size requirements for case control study designs. BMC Med. Res Methodol 19: 1-5.
16. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31: 431-455.
17. Hacek DM, Ogle AM, Fisher A, Robicsek A, Peterson LR (2010) Significant impact of terminal room cleaning with bleach on reducing nosocomial Clostridium difficile. Am J Infect Control 38: 350-353.
18. Tenover FC, Novak-Weekley S, Woods CW, Peterson LR, Davis T, Schreckenberger P, Fang FC, Dascal A, Gerding DN, Nomura JH, Goering RV, Akerlund T, Weissfeld AS, Baron EJ, Wong E, Marlowe EM, Whitmore J, Persing DH (2010) Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J. Clin. Microbiol 48: 3719-3724.
19. Horejsh D, Kampf G (2011) Efficacy of three surface disinfectants against spores of Clostridium difficile ribotype 027. Int J Hyg Environ Health 214: 172-174.
20. Al-Obaydi W, Smith CD, Foguet P (2010) Changing prophylactic antibiotic protocol for reducing Clostridium difficile-associated diarrhoeal infections. J Orthop Surg (Hong Kong) 18: 320-323.
21. Gulihar A, Nixon M, Jenkins D, Taylor GJ (2009) Clostridium difficile in hip fracture patients: prevention, treatment and associated mortality. Injury 40: 746-751.
22. Oake N, Taljaard M, van Walraven C, Wilson K, Roth V, Forster AJ (2010) The effect of hospital-acquired Clostridium difficile infection on in-hospital mortality. Arch Intern Med 170: 1804-1810.